| 1 day | -16.59% |
| Manager | Title | Age | Since |
|---|---|---|---|
Carl Merton
CEO | Chief Executive Officer | 57 | 22/06/2023 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 15/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Chiara
BRD | Director/Board Member | - | 04/11/2016 |
Peter Montour
BRD | Director/Board Member | - | 30/08/2021 |
William Montour
BRD | Director/Board Member | - | 05/01/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/05/23 | Other | Director | 0 | 0.0000% | ||
| 28/04/23 | Option | Director | 8,117 | 0.0189% | ||
| 28/04/23 | Tax | Chief Executive Officer | 3,184,422 | 7.4181% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -16.59% | -39.87% | - | - | 29.39M | ||
| -2.32% | -3.79% | +34.24% | +133.69% | 1,232B | ||
| -2.15% | -2.75% | +36.35% | +82.05% | 656B | ||
| -2.33% | -3.04% | +22.29% | +106.80% | 506B | ||
| -0.86% | -1.48% | +29.11% | +68.88% | 382B | ||
| -3.90% | -6.39% | +42.88% | +35.41% | 340B | ||
| -2.96% | -4.86% | +24.93% | +51.52% | 294B | ||
| -1.33% | -3.17% | -0.79% | +33.47% | 278B | ||
| -3.07% | -5.17% | +29.04% | +67.26% | 240B | ||
| -0.75% | -0.44% | +32.87% | +123.96% | 210B | ||
| Average | -2.84% | -2.30% | +27.88% | +78.12% | 460B | |
| Weighted average by Cap. | -1.18% | -2.67% | +29.96% | +91.23% |
Employees
-
Sector
Pharmaceuticals
















